PRJDB7713: Age associated transcriptome analysis in 5 tissues of zebrafish
Gene Symbol | Gene ID | Gene Info |
---|---|---|
arnt2
|
ENSDARG00000103697 | aryl-hydrocarbon receptor nuclear translocator 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
arnt2 | dr11_v1_chr7_+_10701770_10701770 | 0.88 | 7.0e-32 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_35382482 | 93.46 |
ENSDART00000135284
|
vsnl1a
|
visinin-like 1a |
chr9_-_44295071 | 92.52 |
ENSDART00000011837
|
neurod1
|
neuronal differentiation 1 |
chr13_+_27314795 | 73.90 |
ENSDART00000128726
|
eef1a1a
|
eukaryotic translation elongation factor 1 alpha 1a |
chr11_+_7324704 | 62.33 |
ENSDART00000031937
|
diras1a
|
DIRAS family, GTP-binding RAS-like 1a |
chr5_-_23429228 | 60.22 |
ENSDART00000049291
|
gria3a
|
glutamate receptor, ionotropic, AMPA 3a |
chr5_+_23118470 | 54.80 |
ENSDART00000149893
|
nexmifa
|
neurite extension and migration factor a |
chr5_+_32162684 | 54.26 |
ENSDART00000134472
|
taok3b
|
TAO kinase 3b |
chr19_+_10396042 | 53.58 |
ENSDART00000028048
ENSDART00000151735 |
necap1
|
NECAP endocytosis associated 1 |
chr24_-_11325849 | 52.32 |
ENSDART00000182485
|
myrip
|
myosin VIIA and Rab interacting protein |
chr18_+_7345417 | 51.39 |
ENSDART00000041429
|
glipr1b
|
GLI pathogenesis-related 1b |
chr21_+_6751760 | 49.24 |
ENSDART00000135914
|
olfm1b
|
olfactomedin 1b |
chr19_-_10243148 | 48.17 |
ENSDART00000148073
|
shisa7b
|
shisa family member 7 |
chr19_+_17259912 | 47.99 |
ENSDART00000078951
|
MANEAL
|
si:ch211-30b16.2 |
chr11_+_30513656 | 47.84 |
ENSDART00000008594
|
tmem178
|
transmembrane protein 178 |
chr5_+_55626693 | 45.50 |
ENSDART00000168908
ENSDART00000161412 |
ntrk2b
|
neurotrophic tyrosine kinase, receptor, type 2b |
chr20_+_27331008 | 44.08 |
ENSDART00000141486
|
ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr10_+_22012389 | 43.40 |
ENSDART00000035188
|
kcnip1b
|
Kv channel interacting protein 1 b |
chr4_-_12007404 | 43.18 |
ENSDART00000092250
|
btbd11a
|
BTB (POZ) domain containing 11a |
chr1_-_22757145 | 42.93 |
ENSDART00000134719
|
prom1b
|
prominin 1 b |
chr17_+_15535501 | 42.60 |
ENSDART00000002932
|
marcksb
|
myristoylated alanine-rich protein kinase C substrate b |
chr21_+_6751405 | 42.41 |
ENSDART00000037265
ENSDART00000146371 |
olfm1b
|
olfactomedin 1b |
chr16_-_12953739 | 42.11 |
ENSDART00000103894
|
cacng8b
|
calcium channel, voltage-dependent, gamma subunit 8b |
chr15_-_12319065 | 40.75 |
ENSDART00000162973
ENSDART00000170543 |
fxyd6
|
FXYD domain containing ion transport regulator 6 |
chr5_-_16983336 | 40.52 |
ENSDART00000038740
|
galnt9
|
polypeptide N-acetylgalactosaminyltransferase 9 |
chr2_+_47581997 | 37.57 |
ENSDART00000112579
|
scg2b
|
secretogranin II (chromogranin C), b |
chr12_-_22540943 | 37.19 |
ENSDART00000172310
|
zbtb4
|
zinc finger and BTB domain containing 4 |
chr23_-_8373676 | 36.74 |
ENSDART00000105135
ENSDART00000158531 |
oprl1
|
opiate receptor-like 1 |
chr24_-_3419998 | 36.66 |
ENSDART00000066839
|
slc35g2b
|
solute carrier family 35, member G2b |
chr22_-_21150845 | 35.38 |
ENSDART00000027345
|
tmem59l
|
transmembrane protein 59-like |
chr21_+_30194904 | 35.30 |
ENSDART00000137023
ENSDART00000078403 |
BRD8
|
si:ch211-59d17.3 |
chr9_+_32978302 | 35.17 |
ENSDART00000007630
|
nhlh2
|
nescient helix loop helix 2 |
chr21_+_28958471 | 35.12 |
ENSDART00000144331
ENSDART00000005929 |
ppp3ca
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr21_-_41305748 | 34.98 |
ENSDART00000170457
|
nsg2
|
neuronal vesicle trafficking associated 2 |
chr14_+_8275115 | 34.62 |
ENSDART00000129055
|
nrg2b
|
neuregulin 2b |
chr25_+_19954576 | 34.06 |
ENSDART00000149335
|
kcna1a
|
potassium voltage-gated channel, shaker-related subfamily, member 1a |
chr1_+_33969015 | 33.89 |
ENSDART00000042984
ENSDART00000146530 |
epha6
|
eph receptor A6 |
chr1_+_14283692 | 33.74 |
ENSDART00000017679
|
ppp2r2ca
|
protein phosphatase 2, regulatory subunit B, gamma a |
chr13_+_12299997 | 33.41 |
ENSDART00000108535
|
gabrb1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
chr19_+_15571290 | 33.07 |
ENSDART00000131134
|
foxo6b
|
forkhead box O6 b |
chr14_-_7885707 | 32.95 |
ENSDART00000029981
|
ppp3cb
|
protein phosphatase 3, catalytic subunit, beta isozyme |
chr21_+_5169154 | 32.91 |
ENSDART00000102559
|
zgc:122979
|
zgc:122979 |
chr1_+_49814461 | 32.86 |
ENSDART00000132405
|
lef1
|
lymphoid enhancer-binding factor 1 |
chr2_+_42724404 | 32.70 |
ENSDART00000075392
|
basp1
|
brain abundant, membrane attached signal protein 1 |
chr23_-_26077038 | 32.52 |
ENSDART00000126299
|
gdi1
|
GDP dissociation inhibitor 1 |
chr7_-_56793739 | 32.40 |
ENSDART00000082842
|
si:ch211-146m13.3
|
si:ch211-146m13.3 |
chr1_+_8662530 | 32.20 |
ENSDART00000054989
|
fscn1b
|
fascin actin-bundling protein 1b |
chr15_+_36156986 | 32.03 |
ENSDART00000059791
|
sst1.1
|
somatostatin 1, tandem duplicate 1 |
chr1_+_36436936 | 31.79 |
ENSDART00000124112
|
pou4f2
|
POU class 4 homeobox 2 |
chr14_-_34276574 | 31.61 |
ENSDART00000021437
|
gria1a
|
glutamate receptor, ionotropic, AMPA 1a |
chr1_-_45633955 | 31.44 |
ENSDART00000044057
|
sept3
|
septin 3 |
chr12_-_14922955 | 31.15 |
ENSDART00000002078
|
neurod2
|
neurogenic differentiation 2 |
chr4_+_10888762 | 30.92 |
ENSDART00000136049
|
syt10
|
synaptotagmin X |
chr7_+_25858380 | 30.87 |
ENSDART00000148780
ENSDART00000079218 |
mtmr1a
|
myotubularin related protein 1a |
chr5_+_36415978 | 30.54 |
ENSDART00000084464
|
fam155b
|
family with sequence similarity 155, member B |
chr13_-_30027730 | 30.23 |
ENSDART00000044009
|
scdb
|
stearoyl-CoA desaturase b |
chr9_-_23217196 | 29.85 |
ENSDART00000083567
|
kif5c
|
kinesin family member 5C |
chr2_+_45382433 | 29.81 |
ENSDART00000142251
|
wdr47a
|
WD repeat domain 47a |
chr17_-_22067451 | 29.59 |
ENSDART00000156872
|
ttbk1b
|
tau tubulin kinase 1b |
chr6_+_13920479 | 29.59 |
ENSDART00000155480
|
ptprnb
|
protein tyrosine phosphatase, receptor type, Nb |
chr5_+_36611128 | 29.15 |
ENSDART00000097684
|
nova1
|
neuro-oncological ventral antigen 1 |
chr17_-_17447899 | 28.98 |
ENSDART00000156928
ENSDART00000109034 |
nrxn3a
|
neurexin 3a |
chr14_+_36220479 | 28.85 |
ENSDART00000148319
|
pitx2
|
paired-like homeodomain 2 |
chr16_-_13004166 | 28.85 |
ENSDART00000133735
|
cacng7b
|
calcium channel, voltage-dependent, gamma subunit 7b |
chr21_+_6780340 | 28.43 |
ENSDART00000139493
ENSDART00000140478 |
olfm1b
|
olfactomedin 1b |
chr18_-_44610992 | 28.39 |
ENSDART00000125968
ENSDART00000185836 |
spred3
|
sprouty-related, EVH1 domain containing 3 |
chr11_+_36989696 | 28.30 |
ENSDART00000045888
|
tkta
|
transketolase a |
chr18_+_2837563 | 28.23 |
ENSDART00000171495
ENSDART00000160228 |
fam168a
|
family with sequence similarity 168, member A |
chr4_-_4780667 | 28.09 |
ENSDART00000133973
|
si:ch211-258f14.2
|
si:ch211-258f14.2 |
chr19_-_9882821 | 28.00 |
ENSDART00000147128
|
cacng7a
|
calcium channel, voltage-dependent, gamma subunit 7a |
chr20_-_47731768 | 27.98 |
ENSDART00000031167
|
tfap2d
|
transcription factor AP-2 delta (activating enhancer binding protein 2 delta) |
chr1_-_22834824 | 27.84 |
ENSDART00000043556
|
ldb2b
|
LIM domain binding 2b |
chr17_+_52822831 | 27.79 |
ENSDART00000193368
|
meis2a
|
Meis homeobox 2a |
chr6_-_26559921 | 27.76 |
ENSDART00000104532
|
sox14
|
SRY (sex determining region Y)-box 14 |
chr6_+_33537267 | 27.63 |
ENSDART00000040334
|
pik3r3b
|
phosphoinositide-3-kinase, regulatory subunit 3b (gamma) |
chr8_-_11640240 | 27.60 |
ENSDART00000091752
|
fnbp1a
|
formin binding protein 1a |
chr2_+_31957554 | 27.42 |
ENSDART00000012413
|
ankhb
|
ANKH inorganic pyrophosphate transport regulator b |
chr16_-_13662514 | 27.22 |
ENSDART00000146348
|
shisa7a
|
shisa family member 7a |
chr20_+_20637866 | 27.21 |
ENSDART00000060203
ENSDART00000079079 |
rtn1b
|
reticulon 1b |
chr1_+_6171585 | 27.02 |
ENSDART00000024358
|
prkag3a
|
protein kinase, AMP-activated, gamma 3a non-catalytic subunit |
chr1_+_25783801 | 26.87 |
ENSDART00000102455
|
gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr10_-_19801821 | 26.83 |
ENSDART00000148013
|
gfra2b
|
GDNF family receptor alpha 2b |
chr15_+_33070939 | 26.79 |
ENSDART00000164928
|
mab21l1
|
mab-21-like 1 |
chr1_+_33383971 | 26.72 |
ENSDART00000150043
|
dhrsx
|
dehydrogenase/reductase (SDR family) X-linked |
chr4_-_27350820 | 26.71 |
ENSDART00000145806
|
fam19a5a
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5a |
chr3_-_62380146 | 26.58 |
ENSDART00000155853
|
gprc5ba
|
G protein-coupled receptor, class C, group 5, member Ba |
chr9_-_6661657 | 26.43 |
ENSDART00000133178
ENSDART00000113914 ENSDART00000061593 |
pou3f3a
|
POU class 3 homeobox 3a |
chr7_+_20629411 | 26.37 |
ENSDART00000173710
|
si:dkey-19b23.15
|
si:dkey-19b23.15 |
chr7_+_10701770 | 26.36 |
ENSDART00000167323
|
arnt2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr4_+_9279784 | 26.32 |
ENSDART00000014897
|
srgap1b
|
SLIT-ROBO Rho GTPase activating protein 1b |
chr11_-_24428237 | 25.96 |
ENSDART00000189107
ENSDART00000103752 |
dvl1b
|
dishevelled segment polarity protein 1b |
chr16_+_1802307 | 25.87 |
ENSDART00000180026
|
GRIK2
|
glutamate ionotropic receptor kainate type subunit 2 |
chr5_-_32092856 | 25.53 |
ENSDART00000086181
ENSDART00000181677 |
cabp7b
|
calcium binding protein 7b |
chr5_-_22952156 | 25.21 |
ENSDART00000111146
|
si:ch211-26b3.4
|
si:ch211-26b3.4 |
chr11_+_34824099 | 25.19 |
ENSDART00000037017
ENSDART00000146944 |
slc38a3a
|
solute carrier family 38, member 3a |
chr5_-_28915130 | 25.08 |
ENSDART00000078592
|
npdc1b
|
neural proliferation, differentiation and control, 1b |
chr17_-_45552602 | 24.64 |
ENSDART00000154844
ENSDART00000034432 |
susd4
|
sushi domain containing 4 |
chr5_-_71460556 | 24.38 |
ENSDART00000108804
|
brinp1
|
bone morphogenetic protein/retinoic acid inducible neural-specific 1 |
chr5_+_3501859 | 24.37 |
ENSDART00000080486
|
ywhag1
|
3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 1 |
chr23_-_44494401 | 24.28 |
ENSDART00000114640
ENSDART00000148532 |
actl6b
|
actin-like 6B |
chr17_+_19630272 | 23.92 |
ENSDART00000104895
|
rgs7a
|
regulator of G protein signaling 7a |
chr2_+_49522178 | 23.86 |
ENSDART00000056254
|
stap2a
|
signal transducing adaptor family member 2a |
chr15_-_18574716 | 23.83 |
ENSDART00000142010
ENSDART00000019006 |
ncam1b
|
neural cell adhesion molecule 1b |
chr1_+_33383644 | 23.66 |
ENSDART00000187194
|
dhrsx
|
dehydrogenase/reductase (SDR family) X-linked |
chr8_+_26868105 | 23.60 |
ENSDART00000005337
|
rimkla
|
ribosomal modification protein rimK-like family member A |
chr6_-_18698006 | 23.57 |
ENSDART00000170128
|
rhbdl3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr17_-_20287530 | 23.28 |
ENSDART00000078703
ENSDART00000191289 |
add3b
|
adducin 3 (gamma) b |
chr19_+_41006975 | 23.21 |
ENSDART00000138555
ENSDART00000049842 |
casd1
|
CAS1 domain containing 1 |
chr16_-_33059246 | 23.05 |
ENSDART00000171718
ENSDART00000168305 ENSDART00000166401 |
snap91
|
synaptosomal-associated protein 91 |
chr25_-_36282539 | 23.02 |
ENSDART00000073398
|
slc7a10b
|
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10b |
chr2_-_10188598 | 22.79 |
ENSDART00000189122
|
dmbx1a
|
diencephalon/mesencephalon homeobox 1a |
chr10_+_29963518 | 22.51 |
ENSDART00000011317
ENSDART00000099964 ENSDART00000182990 ENSDART00000113912 |
ntm
|
neurotrimin |
chr6_+_4872883 | 22.24 |
ENSDART00000186730
ENSDART00000092290 ENSDART00000151674 |
pcdh9
|
protocadherin 9 |
chr8_+_10561922 | 22.12 |
ENSDART00000133348
|
fam19a5l
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5-like |
chr3_+_46628885 | 21.94 |
ENSDART00000006602
|
pde4a
|
phosphodiesterase 4A, cAMP-specific |
chr12_+_35119762 | 21.85 |
ENSDART00000085774
|
si:ch73-127m5.1
|
si:ch73-127m5.1 |
chr9_-_20372977 | 21.82 |
ENSDART00000113418
|
igsf3
|
immunoglobulin superfamily, member 3 |
chr2_+_21090317 | 21.36 |
ENSDART00000109568
ENSDART00000139633 |
pip4k2ab
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha b |
chr19_-_10395683 | 21.34 |
ENSDART00000109488
|
zgc:194578
|
zgc:194578 |
chr19_+_30387999 | 21.23 |
ENSDART00000145396
|
tspan13b
|
tetraspanin 13b |
chr21_+_17110598 | 21.12 |
ENSDART00000101282
ENSDART00000191864 |
bcr
|
breakpoint cluster region |
chr9_+_29643036 | 21.06 |
ENSDART00000023210
ENSDART00000175160 |
trim13
|
tripartite motif containing 13 |
chr23_+_13124085 | 20.99 |
ENSDART00000139475
|
samd10b
|
sterile alpha motif domain containing 10b |
chr13_-_20518632 | 20.71 |
ENSDART00000165310
|
gfra1a
|
gdnf family receptor alpha 1a |
chr8_+_49778486 | 20.36 |
ENSDART00000131732
|
ntrk2a
|
neurotrophic tyrosine kinase, receptor, type 2a |
chr17_+_9310259 | 20.09 |
ENSDART00000186158
ENSDART00000190329 |
NPAS3
|
neuronal PAS domain protein 3 |
chr4_+_7888047 | 19.84 |
ENSDART00000104676
|
camk1da
|
calcium/calmodulin-dependent protein kinase 1Da |
chr14_+_19258702 | 19.72 |
ENSDART00000187087
ENSDART00000005738 |
slitrk2
|
SLIT and NTRK-like family, member 2 |
chr18_+_49411417 | 19.64 |
ENSDART00000028944
|
LRFN3
|
zmp:0000001073 |
chr15_+_15856178 | 19.53 |
ENSDART00000080338
|
dusp14
|
dual specificity phosphatase 14 |
chr2_-_15040345 | 19.52 |
ENSDART00000109657
|
si:dkey-10f21.4
|
si:dkey-10f21.4 |
chr25_+_1591964 | 19.41 |
ENSDART00000093277
|
ppm1h
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
chr11_+_30161699 | 19.36 |
ENSDART00000190504
|
cdkl5
|
cyclin-dependent kinase-like 5 |
chr19_+_26718074 | 19.23 |
ENSDART00000134455
|
zgc:100906
|
zgc:100906 |
chr11_-_3959477 | 19.09 |
ENSDART00000045971
|
pbrm1
|
polybromo 1 |
chr11_-_36963988 | 18.89 |
ENSDART00000168288
|
cacna1da
|
calcium channel, voltage-dependent, L type, alpha 1D subunit, a |
chr5_+_27583445 | 18.80 |
ENSDART00000136488
|
zmat4a
|
zinc finger, matrin-type 4a |
chr13_+_12120664 | 18.77 |
ENSDART00000130007
ENSDART00000079443 |
gabra2a
|
gamma-aminobutyric acid type A receptor alpha2 subunit a |
chr8_-_17771755 | 18.69 |
ENSDART00000063592
|
prkcz
|
protein kinase C, zeta |
chr13_+_35925490 | 18.67 |
ENSDART00000046115
|
mfsd2aa
|
major facilitator superfamily domain containing 2aa |
chr10_+_17850934 | 18.58 |
ENSDART00000113666
ENSDART00000145936 |
phf24
|
PHD finger protein 24 |
chr17_+_28340138 | 18.49 |
ENSDART00000033943
|
mdga2a
|
MAM domain containing glycosylphosphatidylinositol anchor 2a |
chr3_+_14768364 | 18.48 |
ENSDART00000090235
ENSDART00000139001 |
nfixb
|
nuclear factor I/Xb |
chr1_-_22756898 | 18.48 |
ENSDART00000158915
|
prom1b
|
prominin 1 b |
chr14_-_47314340 | 18.34 |
ENSDART00000164851
|
fstl5
|
follistatin-like 5 |
chr1_+_37195465 | 18.19 |
ENSDART00000043855
ENSDART00000192580 ENSDART00000181666 |
dclk2a
|
doublecortin-like kinase 2a |
chr7_-_38340674 | 18.12 |
ENSDART00000075782
|
slc7a10a
|
solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10a |
chr16_-_23885482 | 18.11 |
ENSDART00000132243
|
osgin2
|
oxidative stress induced growth inhibitor family member 2 |
chr1_+_31942961 | 17.86 |
ENSDART00000007522
|
anos1a
|
anosmin 1a |
chr20_+_37844035 | 17.77 |
ENSDART00000041397
|
flvcr1
|
feline leukemia virus subgroup C cellular receptor 1 |
chr2_+_25929619 | 17.77 |
ENSDART00000137746
|
slc7a14a
|
solute carrier family 7, member 14a |
chr13_+_12739283 | 17.76 |
ENSDART00000102279
|
lingo2b
|
leucine rich repeat and Ig domain containing 2b |
chr25_+_13406069 | 17.62 |
ENSDART00000010495
|
znrf1
|
zinc and ring finger 1 |
chr1_-_16507812 | 17.47 |
ENSDART00000169081
|
mtmr7b
|
myotubularin related protein 7b |
chr6_-_39489190 | 17.45 |
ENSDART00000151299
|
scn8ab
|
sodium channel, voltage gated, type VIII, alpha subunit b |
chr12_+_9703172 | 17.40 |
ENSDART00000091489
|
ppp1r9bb
|
protein phosphatase 1, regulatory subunit 9Bb |
chr1_-_22512063 | 17.32 |
ENSDART00000031546
ENSDART00000190987 |
chrna6
|
cholinergic receptor, nicotinic, alpha 6 |
chr15_-_31516558 | 17.26 |
ENSDART00000156427
ENSDART00000156072 ENSDART00000156047 |
hmgb1b
|
high mobility group box 1b |
chr17_-_42218652 | 17.23 |
ENSDART00000081396
ENSDART00000190007 |
nkx2.2a
|
NK2 homeobox 2a |
chr21_+_23953181 | 17.06 |
ENSDART00000145541
ENSDART00000065599 ENSDART00000112869 |
cadm1a
|
cell adhesion molecule 1a |
chr4_-_4780510 | 17.04 |
ENSDART00000109609
|
si:ch211-258f14.2
|
si:ch211-258f14.2 |
chr13_+_24022963 | 17.04 |
ENSDART00000028285
|
pgbd5
|
piggyBac transposable element derived 5 |
chr9_-_44289636 | 16.81 |
ENSDART00000110411
|
cerkl
|
ceramide kinase-like |
chr18_-_46208581 | 16.70 |
ENSDART00000141278
|
si:ch211-14c7.2
|
si:ch211-14c7.2 |
chr10_+_23060391 | 16.65 |
ENSDART00000079711
|
slc25a1a
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1a |
chr14_+_32022272 | 16.64 |
ENSDART00000105760
|
zic6
|
zic family member 6 |
chr12_+_19305390 | 16.64 |
ENSDART00000183987
ENSDART00000066391 |
csnk1e
|
casein kinase 1, epsilon |
chr6_-_48473694 | 16.58 |
ENSDART00000154237
|
ppm1j
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J |
chr18_-_23875219 | 16.57 |
ENSDART00000059976
|
nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_-_7917062 | 16.51 |
ENSDART00000177068
|
mmd2b
|
monocyte to macrophage differentiation-associated 2b |
chr14_+_33722950 | 16.38 |
ENSDART00000075312
|
apln
|
apelin |
chr1_+_37195919 | 16.30 |
ENSDART00000159684
ENSDART00000172742 ENSDART00000158395 |
dclk2a
|
doublecortin-like kinase 2a |
chr17_-_33289304 | 16.28 |
ENSDART00000135118
ENSDART00000040346 |
efr3ba
|
EFR3 homolog Ba (S. cerevisiae) |
chr15_+_28482862 | 16.23 |
ENSDART00000015286
ENSDART00000154320 |
ankrd13b
|
ankyrin repeat domain 13B |
chr24_-_11050070 | 16.10 |
ENSDART00000191320
ENSDART00000030409 ENSDART00000191248 ENSDART00000191943 |
asap1b
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1b |
chr13_-_20519001 | 15.80 |
ENSDART00000168955
|
gfra1a
|
gdnf family receptor alpha 1a |
chr2_-_32352946 | 15.77 |
ENSDART00000144870
ENSDART00000077151 |
asap1a
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1a |
chr18_-_23875370 | 15.71 |
ENSDART00000130163
|
nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr23_-_16692312 | 15.57 |
ENSDART00000046784
|
fkbp1ab
|
FK506 binding protein 1Ab |
chr5_-_34185497 | 15.57 |
ENSDART00000146321
|
fibcd1
|
fibrinogen C domain containing 1 |
chr5_-_34185115 | 15.55 |
ENSDART00000192771
|
fibcd1
|
fibrinogen C domain containing 1 |
chr10_-_26744131 | 15.55 |
ENSDART00000020096
ENSDART00000162710 ENSDART00000179853 |
fgf13b
|
fibroblast growth factor 13b |
chr19_+_30388186 | 15.50 |
ENSDART00000103474
|
tspan13b
|
tetraspanin 13b |
chr19_-_28130658 | 15.46 |
ENSDART00000079114
|
irx1b
|
iroquois homeobox 1b |
chr8_+_23147609 | 15.40 |
ENSDART00000180284
|
gid8a
|
GID complex subunit 8 homolog a (S. cerevisiae) |
chr24_-_31846366 | 15.38 |
ENSDART00000155295
|
steap2
|
STEAP family member 2, metalloreductase |
chr8_+_14710542 | 15.32 |
ENSDART00000132899
|
cacna1ea
|
calcium channel, voltage-dependent, R type, alpha 1E subunit a |
chr3_-_19091024 | 15.22 |
ENSDART00000188485
ENSDART00000110554 |
grin2ca
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2Ca |
chr7_-_49800755 | 15.17 |
ENSDART00000180072
|
fjx1
|
four jointed box 1 |
chr22_-_20105969 | 14.95 |
ENSDART00000088687
|
rxfp3.2b
|
relaxin/insulin-like family peptide receptor 3.2b |
chr8_+_49778756 | 14.87 |
ENSDART00000083790
|
ntrk2a
|
neurotrophic tyrosine kinase, receptor, type 2a |
chr1_+_37196106 | 14.82 |
ENSDART00000008756
ENSDART00000157503 ENSDART00000162971 ENSDART00000191004 ENSDART00000078206 ENSDART00000045111 |
dclk2a
|
doublecortin-like kinase 2a |
chr24_-_18179535 | 14.79 |
ENSDART00000186112
|
cntnap2a
|
contactin associated protein like 2a |
chr12_-_48943467 | 14.68 |
ENSDART00000191829
|
CABZ01092907.1
|
|
chr2_-_24603325 | 14.67 |
ENSDART00000113356
|
crtc1a
|
CREB regulated transcription coactivator 1a |
chr4_-_17055782 | 14.61 |
ENSDART00000134595
|
sox5
|
SRY (sex determining region Y)-box 5 |
chr14_-_33328031 | 14.56 |
ENSDART00000137997
|
sept6
|
septin 6 |
chr19_-_1023051 | 14.56 |
ENSDART00000158429
|
tmem42b
|
transmembrane protein 42b |
chr4_-_4706893 | 14.47 |
ENSDART00000093005
|
CABZ01020835.1
|
|
chr2_-_33687214 | 14.41 |
ENSDART00000147439
|
atp6v0b
|
ATPase H+ transporting V0 subunit b |
chr15_-_19128705 | 14.40 |
ENSDART00000152428
|
arhgap32a
|
Rho GTPase activating protein 32a |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.9 | 80.7 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
15.9 | 47.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
13.7 | 41.1 | GO:0042940 | D-amino acid transport(GO:0042940) D-alanine transport(GO:0042941) D-serine transport(GO:0042942) |
13.7 | 54.8 | GO:2000048 | negative regulation of cell-substrate adhesion(GO:0010812) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
12.5 | 62.3 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
12.4 | 37.2 | GO:0060031 | mediolateral intercalation(GO:0060031) |
10.6 | 31.8 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) venous endothelial cell differentiation(GO:0060843) venous endothelial cell fate commitment(GO:0060845) |
9.9 | 49.3 | GO:0006972 | hyperosmotic response(GO:0006972) |
9.5 | 37.8 | GO:0006867 | asparagine transport(GO:0006867) |
9.1 | 45.4 | GO:0060784 | regulation of cell proliferation involved in tissue homeostasis(GO:0060784) |
8.4 | 75.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
8.2 | 24.6 | GO:2000257 | complement activation, alternative pathway(GO:0006957) regulation of protein activation cascade(GO:2000257) |
7.8 | 31.1 | GO:0060074 | synapse maturation(GO:0060074) |
7.6 | 30.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
6.6 | 112.2 | GO:0098943 | neurotransmitter receptor transport, postsynaptic endosome to lysosome(GO:0098943) |
6.2 | 18.5 | GO:0021611 | facial nerve formation(GO:0021611) |
5.8 | 28.9 | GO:0061072 | iris morphogenesis(GO:0061072) |
5.7 | 17.2 | GO:0021530 | spinal cord oligodendrocyte cell fate specification(GO:0021530) |
5.7 | 28.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
5.6 | 16.8 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) regulation of apoptotic cell clearance(GO:2000425) |
5.5 | 44.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
4.7 | 28.4 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
4.7 | 18.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
4.6 | 13.7 | GO:0045830 | response to protozoan(GO:0001562) TRIF-dependent toll-like receptor signaling pathway(GO:0035666) defense response to protozoan(GO:0042832) regulation of isotype switching(GO:0045191) positive regulation of isotype switching(GO:0045830) |
4.5 | 45.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
4.4 | 17.8 | GO:0097037 | heme export(GO:0097037) |
4.4 | 13.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) synaptic vesicle lumen acidification(GO:0097401) regulation of synaptic vesicle lumen acidification(GO:1901546) |
4.3 | 29.9 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
4.2 | 16.6 | GO:0006843 | mitochondrial citrate transport(GO:0006843) |
4.2 | 49.9 | GO:0050714 | positive regulation of protein secretion(GO:0050714) |
4.1 | 16.5 | GO:0046324 | regulation of glucose import(GO:0046324) |
3.9 | 11.7 | GO:0006178 | guanine salvage(GO:0006178) GMP salvage(GO:0032263) guanine biosynthetic process(GO:0046099) |
3.8 | 15.4 | GO:0015677 | copper ion import(GO:0015677) |
3.8 | 26.4 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
3.7 | 26.0 | GO:0090179 | establishment of planar polarity of embryonic epithelium(GO:0042249) establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
3.7 | 25.8 | GO:0002931 | response to ischemia(GO:0002931) |
3.5 | 10.6 | GO:0036314 | response to sterol(GO:0036314) cellular response to sterol(GO:0036315) SREBP-SCAP complex retention in endoplasmic reticulum(GO:0036316) regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
3.4 | 26.9 | GO:0090594 | inflammatory response to wounding(GO:0090594) |
3.1 | 6.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
3.1 | 9.2 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) retrograde trans-synaptic signaling by nitric oxide(GO:0098924) |
3.1 | 39.7 | GO:0048796 | swim bladder maturation(GO:0048796) swim bladder inflation(GO:0048798) |
3.0 | 14.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) protein localization to axon(GO:0099612) |
2.9 | 44.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
2.9 | 23.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
2.9 | 8.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
2.8 | 8.5 | GO:0097264 | self proteolysis(GO:0097264) |
2.8 | 36.7 | GO:0019233 | sensory perception of pain(GO:0019233) |
2.8 | 25.1 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) purinergic receptor signaling pathway(GO:0035587) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
2.7 | 80.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
2.6 | 92.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
2.5 | 17.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
2.5 | 7.4 | GO:1990120 | regulation of nucleobase-containing compound transport(GO:0032239) positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of nucleocytoplasmic transport(GO:0046824) regulation of RNA export from nucleus(GO:0046831) positive regulation of RNA export from nucleus(GO:0046833) messenger ribonucleoprotein complex assembly(GO:1990120) |
2.4 | 24.4 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
2.3 | 7.0 | GO:0016264 | gap junction assembly(GO:0016264) |
2.3 | 7.0 | GO:0061194 | tongue development(GO:0043586) tongue morphogenesis(GO:0043587) taste bud development(GO:0061193) taste bud morphogenesis(GO:0061194) taste bud formation(GO:0061195) |
2.2 | 6.7 | GO:0015874 | norepinephrine transport(GO:0015874) |
2.2 | 44.1 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
2.2 | 13.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
2.2 | 11.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.1 | 27.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
2.1 | 10.4 | GO:0007412 | axon target recognition(GO:0007412) |
2.0 | 10.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
2.0 | 6.0 | GO:0009193 | pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
1.9 | 9.4 | GO:0071881 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway(GO:0071881) |
1.8 | 8.9 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.7 | 10.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.7 | 16.7 | GO:0009303 | rRNA transcription(GO:0009303) |
1.6 | 29.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.6 | 4.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
1.6 | 11.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.6 | 7.9 | GO:0021767 | mammillary body development(GO:0021767) |
1.6 | 32.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
1.5 | 10.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.5 | 9.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.5 | 6.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.5 | 7.5 | GO:0010586 | miRNA metabolic process(GO:0010586) |
1.5 | 13.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) CDP-diacylglycerol metabolic process(GO:0046341) |
1.5 | 39.6 | GO:0048263 | determination of dorsal identity(GO:0048263) |
1.5 | 11.6 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.3 | 22.8 | GO:1902866 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
1.3 | 14.6 | GO:0050936 | xanthophore differentiation(GO:0050936) |
1.3 | 30.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.3 | 6.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.3 | 18.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
1.2 | 6.1 | GO:0032656 | interleukin-13 production(GO:0032616) regulation of interleukin-13 production(GO:0032656) |
1.2 | 37.6 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
1.2 | 6.0 | GO:0042766 | nucleosome mobilization(GO:0042766) |
1.2 | 6.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.1 | 56.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
1.1 | 4.6 | GO:0048618 | post-embryonic foregut morphogenesis(GO:0048618) |
1.1 | 9.1 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
1.1 | 10.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
1.1 | 11.8 | GO:0032196 | transposition(GO:0032196) |
1.0 | 68.0 | GO:0006414 | translational elongation(GO:0006414) |
1.0 | 9.4 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.0 | 39.5 | GO:0006284 | base-excision repair(GO:0006284) |
1.0 | 17.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.0 | 2.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
1.0 | 9.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
1.0 | 6.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.0 | 42.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.0 | 4.9 | GO:0070587 | regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
1.0 | 30.9 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
1.0 | 6.7 | GO:0090243 | fibroblast growth factor receptor signaling pathway involved in somitogenesis(GO:0090243) |
0.9 | 3.8 | GO:2000815 | regulation of mRNA stability involved in response to stress(GO:0010610) regulation of mRNA stability involved in response to oxidative stress(GO:2000815) |
0.9 | 28.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.9 | 19.8 | GO:1990798 | pancreas regeneration(GO:1990798) |
0.9 | 48.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.9 | 6.1 | GO:1903651 | positive regulation of cytoplasmic transport(GO:1903651) |
0.9 | 29.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.8 | 4.2 | GO:0051701 | interaction with host(GO:0051701) |
0.8 | 18.8 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.8 | 24.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.8 | 5.7 | GO:0046037 | GMP biosynthetic process(GO:0006177) GMP metabolic process(GO:0046037) |
0.8 | 6.3 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.8 | 10.9 | GO:0035269 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) protein O-linked mannosylation(GO:0035269) |
0.7 | 4.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.7 | 2.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.7 | 8.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.7 | 8.7 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.7 | 25.9 | GO:0021854 | limbic system development(GO:0021761) hypothalamus development(GO:0021854) |
0.7 | 2.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.7 | 57.9 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
0.7 | 4.2 | GO:0051491 | response to selenium ion(GO:0010269) positive regulation of filopodium assembly(GO:0051491) |
0.7 | 6.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 6.2 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.7 | 5.5 | GO:0032889 | regulation of vacuole fusion, non-autophagic(GO:0032889) |
0.6 | 7.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 28.5 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.6 | 6.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.6 | 12.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.6 | 3.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 11.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.6 | 36.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.6 | 16.5 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 19.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.5 | 36.9 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.5 | 33.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.5 | 6.0 | GO:0030431 | sleep(GO:0030431) |
0.5 | 10.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.5 | 1.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 26.3 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.5 | 27.1 | GO:0031638 | zymogen activation(GO:0031638) |
0.5 | 14.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
0.5 | 48.7 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.5 | 8.6 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 16.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.5 | 2.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 4.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 35.2 | GO:0048675 | axon extension(GO:0048675) |
0.5 | 8.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 12.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.4 | 3.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.4 | 13.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 6.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 2.6 | GO:0035677 | posterior lateral line neuromast hair cell development(GO:0035677) |
0.4 | 9.9 | GO:0070593 | dendrite self-avoidance(GO:0070593) |
0.4 | 2.5 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 25.9 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
0.4 | 5.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 2.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.4 | 45.5 | GO:0021782 | glial cell development(GO:0021782) |
0.4 | 4.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.4 | 2.6 | GO:0045050 | protein insertion into ER membrane by stop-transfer membrane-anchor sequence(GO:0045050) |
0.3 | 9.1 | GO:0032402 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.3 | 7.7 | GO:0048264 | determination of ventral identity(GO:0048264) |
0.3 | 36.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.3 | 10.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 21.7 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.3 | 7.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 9.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 5.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 9.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 16.6 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.3 | 107.4 | GO:0006897 | endocytosis(GO:0006897) |
0.3 | 10.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 32.5 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 12.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 1.5 | GO:0006083 | acetate metabolic process(GO:0006083) acetyl-CoA biosynthetic process from acetate(GO:0019427) |
0.2 | 8.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.2 | 0.9 | GO:0043620 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.2 | 5.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 47.8 | GO:0007411 | axon guidance(GO:0007411) |
0.2 | 17.4 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 13.8 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.2 | 20.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 12.6 | GO:0021510 | spinal cord development(GO:0021510) |
0.2 | 46.9 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.2 | 0.6 | GO:1903225 | negative regulation of endodermal cell fate specification(GO:0042664) negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 4.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.7 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
0.2 | 42.7 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.2 | 6.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.1 | GO:0034504 | protein localization to nucleus(GO:0034504) |
0.2 | 16.3 | GO:1990778 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.1 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 1.0 | GO:0003160 | endocardium morphogenesis(GO:0003160) |
0.1 | 6.6 | GO:0051169 | nucleocytoplasmic transport(GO:0006913) nuclear transport(GO:0051169) |
0.1 | 4.2 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 37.1 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 47.0 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 1.5 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 20.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 8.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 12.5 | GO:0006865 | amino acid transport(GO:0006865) |
0.1 | 6.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 3.9 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 7.3 | GO:0001817 | regulation of cytokine production(GO:0001817) |
0.1 | 5.4 | GO:0042472 | ear morphogenesis(GO:0042471) inner ear morphogenesis(GO:0042472) |
0.1 | 24.9 | GO:0007268 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
0.1 | 0.4 | GO:0032387 | negative regulation of intracellular transport(GO:0032387) |
0.1 | 28.7 | GO:0007420 | brain development(GO:0007420) |
0.1 | 0.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 7.4 | GO:0048511 | rhythmic process(GO:0048511) |
0.1 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 31.7 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 23.3 | GO:0006886 | intracellular protein transport(GO:0006886) |
0.0 | 0.7 | GO:0006000 | fructose metabolic process(GO:0006000) fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 1.3 | GO:0003205 | cardiac chamber development(GO:0003205) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.5 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.3 | 68.1 | GO:0005955 | calcineurin complex(GO:0005955) |
10.9 | 32.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
7.7 | 61.4 | GO:0071914 | prominosome(GO:0071914) |
6.4 | 279.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
4.4 | 26.6 | GO:0070062 | extracellular exosome(GO:0070062) |
3.5 | 10.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.5 | 10.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
3.3 | 13.2 | GO:0043291 | RAVE complex(GO:0043291) |
3.0 | 14.8 | GO:0033010 | paranodal junction(GO:0033010) |
2.6 | 34.1 | GO:0033270 | paranode region of axon(GO:0033270) juxtaparanode region of axon(GO:0044224) |
2.5 | 7.4 | GO:0042382 | paraspeckles(GO:0042382) |
2.4 | 19.1 | GO:0016586 | RSC complex(GO:0016586) |
2.3 | 27.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.2 | 92.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.1 | 29.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
2.1 | 8.5 | GO:0060171 | stereocilium membrane(GO:0060171) |
2.1 | 14.4 | GO:0001650 | fibrillar center(GO:0001650) |
2.0 | 7.8 | GO:0016460 | myosin II complex(GO:0016460) |
1.9 | 40.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.7 | 25.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.5 | 52.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.5 | 6.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
1.4 | 8.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.4 | 45.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.3 | 14.5 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) extrinsic component of presynaptic membrane(GO:0098888) extrinsic component of presynaptic endocytic zone(GO:0098894) |
1.3 | 24.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
1.3 | 40.8 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
1.2 | 7.4 | GO:0016589 | NURF complex(GO:0016589) |
1.2 | 46.0 | GO:0032156 | septin ring(GO:0005940) septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
1.2 | 53.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
1.1 | 6.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.0 | 14.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.9 | 47.7 | GO:0030426 | growth cone(GO:0030426) |
0.9 | 18.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.9 | 7.7 | GO:0032021 | NELF complex(GO:0032021) |
0.8 | 12.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.7 | 13.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.7 | 17.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.7 | 42.6 | GO:0032432 | actin filament bundle(GO:0032432) |
0.7 | 5.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 13.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.6 | 59.8 | GO:0014069 | postsynaptic density(GO:0014069) |
0.6 | 10.7 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 9.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.6 | 10.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 87.2 | GO:0099503 | secretory vesicle(GO:0099503) |
0.5 | 47.8 | GO:0030141 | secretory granule(GO:0030141) |
0.5 | 126.7 | GO:0030424 | axon(GO:0030424) |
0.5 | 13.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 27.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 43.2 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 24.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 29.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.4 | 97.4 | GO:0045202 | synapse(GO:0045202) |
0.4 | 9.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 5.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 26.8 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 11.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 125.9 | GO:0043005 | neuron projection(GO:0043005) |
0.3 | 1.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 10.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 5.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 2.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 15.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 26.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 3.2 | GO:0044545 | NSL complex(GO:0044545) |
0.2 | 5.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 73.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 4.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.2 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 8.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 18.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 24.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 90.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 13.7 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 4.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 48.8 | GO:0005768 | endosome(GO:0005768) |
0.1 | 6.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 8.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 133.6 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.1 | 5.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 4.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 277.7 | GO:0016020 | membrane(GO:0016020) |
0.0 | 13.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 2.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 67.1 | GO:0005634 | nucleus(GO:0005634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.9 | 80.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
11.3 | 68.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
10.8 | 32.5 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
7.9 | 23.6 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) citrate-L-glutamate ligase activity(GO:0072591) |
7.6 | 30.2 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) palmitoyl-CoA 9-desaturase activity(GO:0032896) |
6.3 | 37.8 | GO:0015182 | L-histidine transmembrane transporter activity(GO:0005290) L-asparagine transmembrane transporter activity(GO:0015182) |
6.1 | 91.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
5.5 | 27.4 | GO:0030504 | inorganic diphosphate transmembrane transporter activity(GO:0030504) |
5.5 | 16.4 | GO:0031704 | apelin receptor binding(GO:0031704) |
5.2 | 36.6 | GO:0030274 | LIM domain binding(GO:0030274) |
4.7 | 28.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
4.0 | 31.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
3.9 | 11.7 | GO:0004422 | hypoxanthine phosphoribosyltransferase activity(GO:0004422) |
3.8 | 15.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
3.8 | 26.4 | GO:0019809 | spermidine binding(GO:0019809) |
3.7 | 33.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.5 | 10.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.3 | 13.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
3.3 | 62.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
3.2 | 9.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
3.1 | 30.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
2.5 | 17.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.5 | 35.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.4 | 16.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.2 | 6.7 | GO:0005333 | dopamine transmembrane transporter activity(GO:0005329) dopamine:sodium symporter activity(GO:0005330) norepinephrine transmembrane transporter activity(GO:0005333) norepinephrine:sodium symporter activity(GO:0005334) |
2.2 | 17.8 | GO:0015232 | heme transporter activity(GO:0015232) |
2.1 | 34.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
2.1 | 56.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
2.0 | 6.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.0 | 5.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.0 | 7.8 | GO:0032034 | myosin head/neck binding(GO:0032028) myosin II head/neck binding(GO:0032034) myosin II heavy chain binding(GO:0032038) |
1.8 | 23.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.7 | 41.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.6 | 36.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.6 | 9.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.5 | 57.2 | GO:0019003 | GDP binding(GO:0019003) |
1.5 | 52.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.5 | 131.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.5 | 25.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.5 | 68.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.5 | 14.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.5 | 26.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.4 | 10.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.4 | 12.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
1.4 | 11.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.4 | 7.0 | GO:0060182 | apelin receptor activity(GO:0060182) |
1.4 | 9.6 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
1.4 | 10.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
1.4 | 9.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.3 | 17.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.3 | 22.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.3 | 9.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.3 | 6.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
1.3 | 7.6 | GO:0004997 | thyrotropin-releasing hormone receptor activity(GO:0004997) |
1.2 | 52.3 | GO:0017022 | myosin binding(GO:0017022) |
1.2 | 4.8 | GO:0071253 | connexin binding(GO:0071253) |
1.1 | 41.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.1 | 14.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 8.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.1 | 7.5 | GO:0030371 | translation repressor activity(GO:0030371) |
1.0 | 13.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.0 | 9.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.0 | 17.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.0 | 28.5 | GO:0016208 | AMP binding(GO:0016208) |
1.0 | 12.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.0 | 4.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.0 | 17.5 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.0 | 38.5 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
1.0 | 23.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.9 | 102.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.9 | 5.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.9 | 30.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.9 | 29.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.9 | 10.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.9 | 27.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 6.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 11.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.8 | 32.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.8 | 10.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 69.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.8 | 13.7 | GO:0005272 | sodium channel activity(GO:0005272) cAMP binding(GO:0030552) |
0.7 | 34.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 11.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 6.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.7 | 17.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.7 | 8.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.7 | 23.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.7 | 23.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 4.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.7 | 5.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.7 | 1.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.6 | 6.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 12.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) MAP kinase phosphatase activity(GO:0033549) |
0.6 | 11.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 7.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 18.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.5 | 4.6 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 7.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 15.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 4.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 26.6 | GO:0030295 | kinase activator activity(GO:0019209) protein kinase activator activity(GO:0030295) |
0.5 | 6.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 2.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 2.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.4 | 11.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 7.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 57.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.4 | 2.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 8.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 21.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 8.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 5.2 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.4 | 8.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) kinase inhibitor activity(GO:0019210) |
0.3 | 10.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 21.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 9.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 3.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 9.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 104.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 21.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 6.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 2.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 9.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 6.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 2.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 11.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 1.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 24.6 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.2 | 20.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 12.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 5.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 33.6 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 10.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 73.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 13.7 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 11.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 8.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 13.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 8.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 10.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 12.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 2.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 10.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 143.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 7.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 10.0 | GO:0042802 | identical protein binding(GO:0042802) |
0.1 | 5.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 9.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 62.9 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.1 | 6.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 17.0 | GO:0001653 | peptide receptor activity(GO:0001653) G-protein coupled peptide receptor activity(GO:0008528) |
0.1 | 13.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 7.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 15.3 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 12.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.7 | GO:0008443 | 6-phosphofructo-2-kinase activity(GO:0003873) phosphofructokinase activity(GO:0008443) |
0.1 | 2.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.1 | 40.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 7.6 | GO:0019901 | protein kinase binding(GO:0019901) |
0.0 | 2.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 5.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 9.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 2.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 7.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 68.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.3 | 59.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.2 | 24.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.2 | 30.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.2 | 18.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.9 | 21.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 13.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 27.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 8.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 10.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 27.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 7.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 20.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 6.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 8.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 2.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 5.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 8.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 4.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 92.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
4.0 | 68.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
3.7 | 18.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.8 | 27.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
2.5 | 10.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
2.2 | 33.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.9 | 17.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.8 | 25.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.7 | 13.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.4 | 9.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.2 | 9.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 8.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.2 | 11.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 8.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.1 | 41.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
1.0 | 11.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 11.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 13.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 31.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.8 | 36.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.7 | 7.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 45.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 12.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.6 | 19.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 28.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 12.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.5 | 13.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 6.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 6.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 5.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 12.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 28.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 4.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 4.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 2.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 7.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 4.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 8.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 6.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 3.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |